NVIDIA
NVDA
Salesforce
CRM
Taiwan Semiconductor
TSM
Alibaba
BABA
Oracle
ORCL
US Stock MarketDetailed Quotes
TARO Taro Pharmaceutical Industries
- 42.970
- 0.0000.00%
Trading Jul 25 09:30 ET
1.27BMarket Cap30.05P/E (TTM)
0.000High0.000Low0Volume0.000Open42.970Pre Close0.00Turnover0.00%Turnover Ratio30.05P/E (Static)29.50MShares43.05052wk High0.71P/B347.45MFloat Cap40.45052wk Low--Dividend TTM8.09MShs Float150.996Historical High--Div YieldTTM0.00%Amplitude1.637Historical Low--Avg Price1Lot Size
Taro Pharmaceutical Industries Key Stats
EPS
According to the latest financial report of Taro Pharmaceutical Industries, the latest earnings per share (TTM) for the company is 0.40. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Taro Pharmaceutical Industries's free cash flow? The latest report shows it as 32.45M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Taro Pharmaceutical Industries shows that the company's current ratio is 3.61, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Taro Pharmaceutical Industries, the quick ratio is 3.04, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Taro Pharmaceutical Industries? The latest ROE figure is 0.84%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Taro Pharmaceutical Industries, the total asset return on investment (ROA) is 0.70%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Taro Pharmaceutical Industries's latest financial report to see how their gross margin is doing - currently at 52.98%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Taro Pharmaceutical Industries, the net profit margin is 9.14%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.